Dorflex Turns Scientific Sound Into a Headache Relief Campaign
Dorflex's "Music Experiment" is a 2016 ambient campaign created by Publicis Brasil that used scientifically composed soundscapes to demonstrate and deliver natural headache relief, positioning the brand's core benefit through audio rather than conventional product messaging.
Dorflex occupies a commanding position in the Brazilian healthcare market. According to data cited by adsoftheworld.com and clapboard.com, Dorflex ranked first among all medicines sold in Brazil in 2016, recording sales of approximately R$470.304 million on a MAT December 2016 basis. That market leadership gave Publicis Brasil both the freedom and the imperative to experiment with communication formats that reinforced the brand's authority rather than simply restating it.
Published in Brazil in August 2016, the campaign entered the Health industry conversation at a moment when Dorflex was deepening its direct-to-consumer relationship, having transitioned away from primarily professional and medical promotion in prior years, as documented by Meioemensagem Com Br and Propmark Com Br. The "Music Experiment" represented a deliberate shift toward ambient and digital content formats, replacing product-led messaging with an experiential proposition: a piece of music engineered to reduce head pain. The campaign comprised a single media asset, and its power resided entirely in that restraint. Rather than explaining headache relief, Dorflex offered it — making the audience participant and proof point simultaneously. This approach earned the campaign a Clapboard Score of 69 out of 100, reflecting creative ambition balanced against the inherent measurability challenges of ambient work.
Dorflex held first place in Brazil's OTC medicine rankings in 2016. Maintaining that leadership required more than promotional repetition — it demanded a communication idea that could deepen consumer trust while expanding the brand's cultural presence beyond pharmacy shelves.
The Brazilian analgesic category in 2016 was intensely competitive. According to brazcanchamber.org and Otempo Com Br, analgesics, cough-and-cold products, and vitamins and minerals together represented approximately three-fifths of Brazil's total OTC sales, making the segment one of the country's most contested consumer healthcare battlegrounds. Neosaldina, as reported by Pantheon Ufrj Br, held the highest indicative unit share in Brazil's analgesic sub-segment, while Torsilax ranked fifth among the country's best-selling medicines in 2016 with sales of approximately R$215.3 million, according to the same source. Against competitors of that scale and penetration, a conventional product-superiority message risked blending into category noise.
Publicis Brasil's strategic response, as documented by adsoftheworld.com and adlatina.com, was to anchor the campaign in science rather than sentiment. The concept of a scientifically composed soundscape gave Dorflex a claim that neither Neosaldina nor Torsilax had staked: that the brand understood headache relief deeply enough to encode it into music. Planner Diana Santos shaped this strategic rationale, connecting a genuine consumer tension — the desire for relief that does not require swallowing a pill — with a brand already trusted for fast-acting analgesic action. By addressing the moment before or instead of medication, the campaign extended the brand's relevance without diluting its core positioning around effective headache relief.
The creative execution of "Music Experiment" rested on a single, disciplined idea: commission and produce a piece of music that was scientifically structured to alleviate head pain, then release it as the campaign itself.
Creative directors Hugo Rodrigues and Kevin Zung led the conceptual development at Publicis Brasil, with creatives Cícero Souza, Alex Adati, Laercio Lopo, and Pedro Lazera contributing to the execution, as documented by adsoftheworld.com and clapboard.com. Production was managed by Tato Bono, with traffic handled by Rose Ramalho. The decision to classify the campaign under the ambient medium was precise: the work was designed to exist in the listener's environment, functioning as relief rather than interruption.
The scientific music concept drew on research into sound therapy and psychoacoustics — the study of how human perception processes audio — to construct a listening experience with a therapeutic intent. This gave the single media asset a dual function: it served simultaneously as the creative execution and as a demonstration of the brand's efficacy claim. In a category where competing brands such as Neosaldina relied on conventional television and pharmacy-facing communications, Dorflex's choice to make the consumer's headache the medium's subject matter was a structurally distinctive move, as observed by adlatina.com and clios.com.
The ambient format also carried an implicit argument about the brand's character. Dorflex was not presenting itself as a product demanding attention but as a solution offering relief on the consumer's own terms. Production credits for the specific audio composers involved in the scientific music composition are not fully detailed in publicly available documentation, though the broader creative and production team is attributed through adsoftheworld.com and clapboard.com.
Dorflex grew its reported Brazilian sales from approximately R$416.568 million in 2015 to approximately R$470.304 million in 2016, implying year-on-year growth of approximately 12.9 percent, according to data cited by adsoftheworld.com and clapboard.com. No verified campaign-specific performance data attributable solely to "Music Experiment" is publicly available for this execution.
That commercial trajectory, however, provides meaningful structural context for evaluating the campaign's role. The shift to direct-to-consumer ambient and digital formats — of which "Music Experiment" was a signal example — coincided with a period of accelerating market share consolidation for Dorflex, as reported by otempo.com.br and brazcanchamber.org. A campaign that positions relief as an experience rather than a transaction supports brand equity in ways that are cumulative rather than immediately attributable to a single activation.
The campaign's submission to Clio Awards, as documented by clios.com, indicates external recognition of its creative merit within the health and wellness advertising space, further validating Publicis Brasil's approach. The Clapboard Score of 69 out of 100 reflects a campaign that executes a genuinely novel concept with precision but operates within the inherent limitations of ambient single-asset work: reach is constrained, measurability is indirect, and the scientific music proposition requires consumer participation to fully land. Within those structural parameters, "Music Experiment" stands as an efficient deployment of brand authority — using Dorflex's market leadership in Brazil to take a creative risk that reinforced rather than risked its positioning around trusted headache relief.
The Dorflex Music Experiment was a 2016 ambient campaign created by Publicis Brasil in Brazil. It used a scientifically composed piece of music intended to provide natural headache relief, positioning the brand's benefit through audio experience rather than conventional product advertising. The campaign comprised a single media asset.
Publicis Brasil created the campaign for Dorflex, a Sanofi-Aventis analgesic brand. Creative directors Hugo Rodrigues and Kevin Zung led the work, supported by creatives Cícero Souza, Alex Adati, Laercio Lopo, and Pedro Lazera, with planning by Diana Santos and production managed by Tato Bono, as documented by adsoftheworld.com.
Dorflex held first place in Brazilian medicine sales in 2016, according to clapboard.com. Scientific music allowed the brand to demonstrate headache relief expertise rather than restate it, differentiating from analgesic competitors such as Neosaldina and Torsilax through an experiential proposition grounded in psychoacoustic research.
Dorflex ranked first among all medicines sold in Brazil in 2016, recording sales of approximately R$470.304 million on a MAT December 2016 basis, according to data cited by adsoftheworld.com and clapboard.com. That represented growth of approximately 12.9 percent from its 2015 reported sales figure of approximately R$416.568 million.
The Dorflex Music Experiment received a Clapboard Score of 69 out of 100. This reflects a creatively ambitious ambient concept executed with precision, balanced against the structural challenges of single-asset ambient work, including limited reach and indirect measurability, within Brazil's highly competitive healthcare advertising market.
The Dorflex Music Experiment was submitted to the Clio Awards, as documented by clios.com, indicating external recognition of its creative merit in healthcare advertising. The campaign was also documented by adlatina.com and adsoftheworld.com, reflecting regional and international industry interest in Publicis Brasil's ambient approach for Dorflex in 2016.
Creative Collaboration Platform: The Backbone of Modern Creative WorkWhat is a creative collaboration platform?Clapboard defines a creative collaboration platform as the operational core for today’s distributed creative teams. This is not a collection of digital collaboration tools stitched together; Clapboard’s system
Understanding the Creative Production MarketplaceWhat is a Creative Production Marketplace?Clapboard defines a creative production marketplace as a structured ecosystem where brands, agencies, and production talent converge to execute video, advertising, and branded content at scale. Unlike the legacy agency or freelanREAD FULL ARTICLE
The Urgent Need for a Creative Production Operating SystemWhy Traditional Creative Production Models Break DownClapboard sees the creative production landscape shifting under pressure. Content velocity is no longer a buzzword—it’s a mandate. Modern advertising demands relentless output across dozens of channels, each wREAD FULL ARTICLE
